Revenio Group Corporation withdrew its earlier earnings guidance by a stock exchange release published on 2 April 2020. At that stage, the effects of the Covid-19 pandemic on the rest of the year were particularly hard to assess, and the company therefore did not give any new earnings guidance for the year 2020.
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact
Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. The Board of Directors of Revenio Group Corporation decided, on 15 February 2021, on the basis of the share issue authorisation granted to the Board of Directors by the company's Annual General Meeting held on 8 June 2020, to issue shares in a directed share issue without payment to pay the shares earned by the company’s key persons during the performance period 2018-2020 of the share-based incentive … 2021-03-03 Find the latest REVENIO GROUP OYJ REVENIO GROUP (0KFH.L) stock quote, history, news and other vital information to help you with your stock trading and investing. Revenio Group Corporation, Stock Exchange Release, March 19, 2021 at 9.10 EET Restricted share plan directed to Oculo’s key employees Revenio Group Corporations (“Revenio”, “Company”) Board of Directors has launched a restricted share plan arrangement (the “Arrangement”) which is related to the previously today published acquisition of the Australian CERA Technologies Pty Ltd ("Oculo"). How has Revenio Group Oyj's share price performed over time and what events caused price changes?
Revenio Group Oyj Share Chart - 0KFH. Current Price. 15.26. 0.00.
Revenio Research concentrates on the commercialization of systems supporting the diagnosis of and treatment planning for skin cancer and asthma. In 2019, Revenio Group's net sales totalled EUR 49.5 million, with its net operating profit standing at 25.5%.
Köp aktier i Revenio Group Oyj - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Revenio Group Corporation, Stock Exchange Release, December 29, 2020 at 9:00 INCREASED NUMBER OF SHARES ENTERED INTO Today, 5.9 - 6.04, Shares 1, 19,888,560, Week, -1.95.
Få omedelbar tillgång till detaljerad information om tekniska analyser och handelssignaler för Revenio Group Co aktien.
Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V. Very long text with the purpose to strech the component dynamically in all cases without unnecessary css declarations. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.
0.00%. 0.0000. 1.33B. 117.30. 0.42. Hälsoteknologi · Medicinska specialiteter · TTALO. Terveystalo Oy Class A. €10.10.
Vårdcentralen vintergatan
Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Revenio Group Corporation, Stock Exchange Release, December 29, 2020 at 9:00 INCREASED NUMBER OF SHARES ENTERED INTO Today, 5.9 - 6.04, Shares 1, 19,888,560, Week, -1.95. 52 Week, 4.49 - 15.95, Mkt Cap of share series 2, 120,126,902, Month, 0.67. Year, 5.62 - 6.94, Liquidity Today, 2.7 - 2.77, Shares 1, 149,821,939, Week, 0.0.
Deliver actionable insights. Daily across the stocks, indices and commodities that matter most to your portfolio
As of March 2021 Revenio has a market cap of $1.65 B. This makes Revenio the is the total market value of a publicly traded company's outstanding shares
Revenio Group Corporation (REVXF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Barnarbete 1800-talet sverige
foto jonkoping
sverige kanada hockey live
gaseosa fanta historia
mailadresser domstolar
vascular doppler device
REVENIO GROUP OYJ (HEL:REG1V) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share REVENIO GROUP OYJ | NASDAQ HELSINKI LTD: REG1V | NASDAQ HELSINKI LTD
2016. Aktier Rethinking Care, Revenio Group Oyj, Rezidor, RhoVac, Rias B Scandinavia's largest social investing site for stocks and funds.
Revenio Group Corporation, Stock Exchange Release, March 19, 2021 at 9.10 EET Restricted share plan directed to Oculo’s key employees Revenio Group Corporations (“Revenio”, “Company”) Board of Directors has launched a restricted share plan arrangement (the “Arrangement”) which is related to the previously today published acquisition of the Australian CERA Technologies Pty Ltd ("Oculo").
Symbol, REG1V. Market, Helsinki. Market Cap (mil), 1.459,14. Volatility, 0,43. Beta, 0,55. Correlation, 0,30.
Revenio is a global leader in ophthalmological devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. Revenio is a health tech group operating on the international market and a global leader in ophthalmological devices and solutions. Revenio Group 's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), retinal imaging devices, and perimeters under the iCare brand. Revenio Group Corporation (REVXF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.